Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay.
Clinical laboratories currently estimate low-density lipoprotein cholesterol using the Friedewald formula, which requires fasting specimens and is subject to error with increasing triglyceride levels. We describe a rapid method for isolating low-density lipoproteins using the Direct LDL Immunoseparation Reagent for subsequent measurement of cholesterol by conventional assay. This method meets current guidelines for precision with within-run and run-to-run coefficients of variation of less than 3%. Results are in good agreement with the beta quantification reference method (Direct LDL-C = 1.03 [beta quantification] -0.06 mmol/L, [2.4 mg/dL] r = 0.980), there is minimal bias associated with increasing triglycerides or high-density lipoprotein cholesterol, and patient fasting is not required for accurate analysis. The Direct LDL Immunoseparation Reagent overcomes drawbacks of the Friedewald formula and appears to be suitable for accurate quantitation of low-density lipoprotein cholesterol in the routine laboratory.
Pisani
T
T
Research Department, Genzyme Diagnostics, Cambridge, Massachusetts 02139, USA.
Gebski
C P
CP
Leary
E T
ET
Warnick
G R
GR
Ollington
J F
JF
D015982:Bias; D008078:Cholesterol, LDL / Q000032:analysis* / Q000302:isolation & purification*; D002846:Chromatography, Affinity / Q000379:methods*; D005215:Fasting; D006801:Humans; D007122:Immunoelectrophoresis; D015203:Reproducibility of Results; D014280:Triglycerides / Q000032:analysis / Q000097:blood
D008078:Cholesterol, LDL; D014280:Triglycerides